Clinical Trial Update: Determination of Drug Levels for Pharmacotherapy of Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial update focusing on determining drug levels for pharmacotherapy in heart failure with reduced ejection fraction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: University Hospital Ostrava | Conditions: Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: NOT_YET_RECRUITING